July 23, 2019
From ancestry to health traits – how do I know if genetic testing may be right for me?
By Sharon Rosen
Article by Shannon Wieloch Last month we posted a blog on helpful tips to know before taking a DNA test. In part II of this topic, we delve deeper into the types of genetic testing commonly available to help you decide what type of testing may be right for you. Some genetic tests inform you […]
Tags: #disease risk, #drug-gene reactions, #Genetic diseases, #hereditary diseases, ancestry, at home DNA tests, carrier screening, center for individualized medicine, direct-to-consumer genetic tests, dna test, Genetic Counseling, Genetic Counselor
July 3, 2017
Trying to quit smoking? Genetics may help find the right plan for success
By Sharon Rosen
After trying different methods, why do many people have difficulty quitting smoking? That’s a question Rachel Tyndale, Ph.D., is asking as part of her research into smoking cessation therapy. As senior scientist and head of the Pharmacogenetics Lab in the Campbell Family Mental Health Research Institute at University of Toronto, Dr. Tyndale is using molecular […]
Tags: #CIMCon17, #DNA analysis, #Dr. J. Steven Leeder, #Dr. Rachel Tyndale, #drug-gene reactions, #Individualizing Medicine 2017, #preemptive pharmacogenomics, #smoking cessation, center for individualized medicine, DNA Sequencing, Dr. Eric Matey, Dr. Liewei Wang
June 30, 2017
Pharmacogenomics – striving for safer, more effective drugs for you
By Sharon Rosen
At Mayo Clinic, pharmacogenomics – how your genes impact the way you process medications – is helping doctors to take the guess work out of selecting safer, more effective treatment for patients. Mayo researchers have been leaders in developing DNA tests and identifying drug-gene interactions that affect a patient’s response to many medications, such as […]
Tags: #CIMCon17, #drug safety, #drug-gene reactions, #Karen Daggett, center for individualized medicine, Dr. Eric Matey, Dr. Liewei Wang, Dr. Richard Weinshilboum, Heart Disease, mayo clinic, Mayo Clinic Pharmacogenomics Program, medical research
June 1, 2017
Mapping your DNA: Mayo patient shares her experience
By Sharon Rosen
Sandy Pobanz knows Mayo Clinic’s campus in Arizona very well. She volunteers with the Mayo Clinic Caring Canines Therapy Dog Program with her English golden retrievers, Benji and Teddy. They provide a special brand of comfort to patients in the Outpatient Radiation Oncology waiting area on Mayo Clinic’s Arizona campus in Scottsdale and Mayo Clinic […]
Tags: #benefactor, #CIMCon17, #disease risk, #DNA sequencing tests, #drug-gene reactions, #pharmacogenomics testing, #Sandy Pobanz, #Warfarin, center for individualized medicine, DNA, Genetic Counseling, Genetic Counselor
April 14, 2017
Precision care for heart disease – a practical approach
By Sharon Rosen
Heart disease can sometimes be a silent killer. Many of us know seemingly healthy people who’ve suddenly or unexpectedly had a heart attack. It can be shocking when people who are at a a healthy weight and exercise regularly die from heart disease that they never knew they had. Many forms of heart disease can […]
Tags: #atrial fibrillation, #cardiology, #Dr. Iftkhar Kullo, #Dr. John Giudicessi, #Dr. Michael Ackerman, #drug-gene reactions, #familial cardiovascular diseases, #sudden cardiac death, #targeted therapies, center for individualized medicine, coronary heart disease, Genetic Testing
March 30, 2017
Coming to your doctor’s office: the right drug at the right dose for you
By Sharon Rosen
By Susan Buckles We at the Center for Individualized Medicine have big dreams for our patients. One of our aspirations is that all Mayo Clinic patients could get genetic testing to find the safest, most effective medication for them. It’s known as pharmacogenomics – tapping your unique genetic makeup to find precise therapies that work […]
Tags: #drug-gene reactions, #Huffington Post, #PGx testing, center for individualized medicine, Dr. Eric Matey, mayo clinic, medical research, pharmacogenomics
March 17, 2017
The power of pharmacogenomics: one physician’s ‘aha moment’
By Sharon Rosen
Seeing is believing – that saying is especially true for Fadi Shamoun, M.D., a consultant and assistant professor in the Department of Cardiovascular Diseases at Mayo Clinic’s campus in Arizona. Dr. Shamoun was aware of the potential value of pharmacogenomics testing, which examines how a patient’s genetic makeup could impact the way he or she […]
Tags: #anti-coagulation medication, #Dr. Fadi Shamoun, #drug-gene reactions, #PGx testing, #Warfarin, antidepressants, center for individualized medicine, mayo clinic, medical research, pharmacogenomics
March 3, 2017
Test reveals the right drug to help one patient manage panic attacks – finally
By Sharon Rosen
When it comes to medications, one size does not fit all. One of the areas where precision medicine has made the biggest impact is in developing tests to help physicians identify which medication will provide the greatest benefit and reduce harmful side effects for patients. Pharmacogenomics tests show how a patient’s genetic makeup impacts the […]
Tags: #anti-anxiety medication, #drug-gene reactions, #primary scleroscing cholangitis, center for individualized medicine, Dr. Konstantinos Lazaridis, mayo clinic, medical research, PGx, pharmacogenomics
January 10, 2017
8 steps to implementing pharmacogenomics into your clinical practice
By Sharon Rosen
Article by Susan Buckles, Public Affairs Change is rarely easy. Often times the more challenging the hurdles, the more rewarding are the results. Such may be the case with implementing pharmacogenomics, the practice of prescribing medications matched to your genetic makeup — medications that are most likely to work and have the fewest side effects. Mayo […]
Tags: #Dr. Pedro Caraballo, #drug-gene reactions, #research model, center for individualized medicine, Genetic Testing, mayo clinic, medical research, PGx, pharmacogenomics
November 10, 2016
By Sharon Rosen
One size does not fit all – especially when it comes to medications. Pharmacogenomics is the study of how your individual genetic characteristics impact your response to medications. The RIGHT study, done at Mayo Clinic, found that 99 percent of people studied had a genetic variation that affects how they respond to a drug therapy. […]
Tags: #Dr. Robert Freimuth, #drug-gene reactions, #Genetic data, #PrecisionMedicine, #RIGHT 10K study, center for individualized medicine, Dr. Liewei Wang, Dr. Richard Weinshilboum, mayo clinic, PGx, pharmacogenomics